Caplin Point Laboratories LimitedNSE: CAPLIPOINT

Press Release Feb 14 2023

Feb 14, 2023 at 7:20 PM UTC

Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated February 14, 2023, titled "CAPLIN STERILES GETS USFDA APPROVAL FOR CARBOPROST TROMETHAMINE INJECTION USP".

View Attachment